Nvidia's Margin Pressure Reinforces HBM Tightness, but Micron's Ceilings Limit Upside

What happened

The Motley Fool article posits that Nvidia's projected gross margin decline stems from rising high-bandwidth memory (HBM) costs, which now account for an estimated 30-40% of AI accelerator bill-of-materials. This reinforces our existing view that HBM remains a critical bottleneck in AI infrastructure, with only Samsung, SK Hynix, and Micron as qualified suppliers. Our analysis already incorporates sustained hyperscaler demand and tight memory supply through early 2027, as reflected in Micron's fiscal Q3 revenue of $41.5 billion and 85% gross margin. However, the key constraint remains Micron's strategic customer agreements, which cover roughly 40% of revenue under fixed prices or price bands near 2Q26 levels, capping upside from any further spot-price appreciation. Consequently, while the news is incrementally supportive of the demand thesis, it does not alter our WAIT rating or the $820 attractive entry level.

Implication

Investors should recognize that HBM's expanding share of AI accelerator costs strengthens the multi-quarter demand visibility for Micron through 2027. Yet, Micron has deliberately traded some spot-price upside for contracted volume and deposits, which means the company's earnings may not fully capture any further increase in HBM prices. At the current price of $938.4, the stock already reflects sustained AI-memory tightness, leaving limited margin of safety. A more constructive stance would require evidence that Micron is expanding its strategic agreements while maintaining margins above 86%, or a pullback to the $820 level. Until such evidence emerges, the balanced risk-reward justifies holding rather than adding new positions.

Thesis delta

The article adds a specific data point that HBM composes 30-40% of AI accelerator costs, reinforcing the demand durability assumption in our base case. However, it fails to address the downside mechanism we flagged: strategic customer agreements cap realized pricing even in a stronger HBM market. Therefore, the investment thesis is unchanged: WAIT, with an attractive entry below $820 and a 3-6 month reassessment window.